# Risk Factor Control Before Orthopedic Surgery

> **NCT01837069** · PHASE4 · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 198 (actual)

## Conditions studied

- Osteoarthritis
- Cardiovascular Disease

## Interventions

- **DRUG:** Metoprolol
- **DRUG:** Lisinopril
- **DRUG:** Atorvastatin
- **BEHAVIORAL:** Lifestyle counseling

## Key facts

- **NCT ID:** NCT01837069
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2018-04-02
- **Final completion:** 2018-04-02
- **Target enrollment:** 198 (ACTUAL)
- **Why stopped:** Low recruitment / DSMB approval to halt recruitment
- **Last updated:** 2020-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01837069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01837069, "Risk Factor Control Before Orthopedic Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01837069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*